NasdaqCM - Nasdaq Real Time Price USD
Benitec Biopharma Inc. (BNTC)
13.57
-0.01
(-0.07%)
As of 1:40:55 PM EDT. Market Open.
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Cash Flow
-21,750
-19,403
-18,012
-15,899
-12,832
Investing Cash Flow
-191
-179
-1
-13
-221
Financing Cash Flow
79,598
68,029
16,015
0
22,522
End Cash Position
78,045
50,929
2,490
4,076
19,784
Capital Expenditure
--
-179
-1
-13
-221
Issuance of Capital Stock
82,528
73,921
17,884
0
25,750
Free Cash Flow
-21,941
-19,582
-18,013
-15,912
-13,053
6/30/2021 - 6/24/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ERAS Erasca, Inc.
1.2150
-4.33%
EWTX Edgewise Therapeutics, Inc.
14.51
-0.31%
IMCR Immunocore Holdings plc
28.70
+3.65%
DNTH Dianthus Therapeutics, Inc.
19.25
+1.85%
RLYB Rallybio Corporation
0.3144
+1.60%
EMBT Ember Therapeutics, Inc.
0.0001
0.00%
OCS Oculis Holding AG
17.28
0.00%
PTP.DE Pentixapharm Holding AG N
2.9350
+1.56%
ELVN Enliven Therapeutics, Inc.
17.79
-10.56%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
309.800
-1.09%